Stockreport

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Profusa, Inc.  (PFSA) 
PDF Study evaluates Lumee™ Oxygen tissue monitoring platform with transcutaneous partial pressure of oxygen (tcpO2) in peripheral artery disease patients BERKELEY, Calif, N [Read more]